Search Page
Save citations to file
Email citations
            Email address has not been verified. Go to
            
              My NCBI account settings
            
            to confirm your email and then refresh this page.
          
        Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results | 
|---|---|
| 2021 | 1 | 
| 2023 | 1 | 
| 2024 | 1 | 
| 2025 | 1 | 
Search Results
3 results
Results by year
        Filters applied: . Clear all
      
    
    Page 1
  
  
  
  
    
      
  
        
          
            
            
            
              
                Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States.
              
            
            
            
              
            
            
              
            
          
        
      
      
        
  
      
    
  
    
      
        
        
      
    
    
    Vaccine. 2023 May 26;41(23):3506-3517. doi: 10.1016/j.vaccine.2023.04.022. Epub 2023 May 3.
    Vaccine. 2023.
  
  
  PMID: 37147201
  Free article.
  
    
  
  
  
  
          
        
        
          
        
          
            
            
            
              
                A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs titers.
              
            
            
            
              
            
            
              
            
          
        
      
      
        
  
  
    
      
        Berthoud TK, Ahmed T, Nadia W, Petrov I, Yang L, Colledge D, Hammond R, Soare C, Ontsouka B, Plaskin D, Anderson DE, Diaz-Mitoma F.
        
      
    
    Berthoud TK, et al.
    Vaccine. 2025 Jan 1;43(Pt 2):126513. doi: 10.1016/j.vaccine.2024.126513. Epub 2024 Nov 12.
    Vaccine. 2025.
  
  
  PMID: 39536477
  
  
    
  
  Clinical Trial.
  
  
          
        
        
          
  Item in Clipboard
  
        
          
            
            
            
              
                Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.
              
            
            
            
              
            
            
              
            
          
        
      
      
        
  
  
    
      
        Vesikari T, Langley JM, Segall N, Ward BJ, Cooper C, Poliquin G, Smith B, Gantt S, McElhaney JE, Dionne M, van Damme P, Leroux-Roels I, Leroux-Roels G, Machluf N, Spaans JN, Yassin-Rajkumar B, Anderson DE, Popovic V, Diaz-Mitoma F; PROTECT Study Group.
        
      
    
    Vesikari T, et al.
    Lancet Infect Dis. 2021 Sep;21(9):1271-1281. doi: 10.1016/S1473-3099(20)30780-5. Epub 2021 May 11.
    Lancet Infect Dis. 2021.
  
  
  PMID: 33989539
  
  
    
  
  Clinical Trial.
  
  
          
        
        
          
  Item in Clipboard
  
      Cite
    
    Cite
    ARTICLE TYPE
        ARTICLE LANGUAGE
        AGE
        Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.
    
    
  